“He’s Going to Die” — Prayers Pour In for Joe Biden — Tragic News
Former First Lady Jill Biden has offered one of her most candid accounts yet of former President Joe Biden’s battle with metastatic prostate cancer, acknowledging her fear of losing her husband while also pointing to recent test results that the family views as encouraging.
Speaking on The Jamie Kern Lima Show this week, Jill Biden, 75, described the emotional weight of watching her husband live with an aggressive cancer that was first publicly disclosed in May 2025 and had already spread to his bones at the time of diagnosis.
“Of course I’m scared,” Jill said. “I mean, first of all, he’s almost 10 years older than I am. And with an illness … you kinda can’t let your head go there.”
“It’s like, you can’t imagine life without them. But you know they’re going to die — just like I know I’m going to die,” she continued. “So part of it, you accept.”
Jill described the former president as “strong” and “resilient,” saying he has continued to approach the illness in much the same way he has dealt with other crises in the family’s life. She said he has not spoken to her at length about fears he may have about his prognosis.
“He’s always been the strength of our family,” she said.
Rather than organizing their daily life around the possibility of death, Jill said the couple has tried to focus on time together, family and experiences that still bring them joy.
“We can’t look at life that way … We look at it like, ‘Joe has cancer. He’s gonna die, so let’s make the most of every moment,’ ” Jill said.
“‘Let’s be together … let’s find things that bring us joy. Let’s make this a positive journey’ — I mean, not a negative journey, because how can you live with that every day?” she added. “You can’t. It’s too heavy.”
Her comments came as she also shared a more detailed medical update. In the same podcast appearance, Jill said her husband had recently undergone scans that the family considered “very optimistic.” She said his prostate-specific antigen, or PSA, level was at zero and said doctors were no longer seeing cancer in the prostate itself, though the disease in his bones remains the more serious concern.
Jill also said the medications required to manage the disease have been difficult and that the illness has noticeably reduced the energy of a man she long described as constantly active. She characterized the overall prognosis with cautious optimism, saying doctors had told the family they did not necessarily expect prostate cancer to be the ultimate cause of his death.
That distinction is important because Biden’s illness has been metastatic from the time it was publicly announced. A low PSA or a strong response in the prostate does not by itself erase the significance of cancer that has spread elsewhere in the body, and Jill has repeatedly emphasized that the bone involvement changed the family’s understanding of the disease.
Joe Biden’s office announced the diagnosis on May 18, 2025, after he had been evaluated for increasing urinary symptoms and doctors found a prostate nodule. According to the statement released at the time, he had prostate cancer with a Gleason score of 9, placing it in Grade Group 5, with metastasis to the bone.
Grade Group 5 is the highest grade category used to describe how abnormal prostate cancer cells appear under a microscope and is associated with a more aggressive form of the disease. Biden’s office nevertheless said the cancer appeared to be hormone-sensitive, a characteristic that can make it responsive to treatments that suppress or block the hormones prostate cancer often uses to grow.
After the diagnosis became public, Biden thanked supporters for their messages and said he and Jill had learned through previous family tragedies that they were “strongest in the broken places.” His family and physicians initially reviewed treatment options before he began therapy.
By late May 2025, Biden said publicly that treatment had started and that doctors were optimistic. Several months later, in October, a spokesperson confirmed that the former president was receiving radiation therapy and hormone treatment as part of his prostate cancer care.
Hormone therapy is a central treatment for metastatic hormone-sensitive prostate cancer because it lowers or blocks androgens such as testosterone that can fuel cancer growth. The National Cancer Institute says modern treatment for metastatic hormone-sensitive disease often combines androgen-deprivation therapy with additional hormone-blocking drugs and, in some cases, chemotherapy, depending on a patient’s overall condition and the extent of the disease.
Bone metastases are also a major reason doctors closely monitor pain, mobility and quality of life in advanced prostate cancer. The National Cancer Institute notes that cancer that has spread to bone can produce substantial pain and other complications, with treatment tailored to the individual patient’s symptoms and response.
Those concerns took on new urgency earlier this month when Hunter Biden gave a stark description of his father’s condition during an interview with the BBC.
“The cancer has spread, metastasized into his bones and further,” Hunter Biden said. “It’s very painful and it’s very debilitating in many respects.”
Hunter became emotional as he discussed what the family has been watching privately.
“It’s really sad to watch,” he said. “The only thing that I’d say about my dad, about his health right now, is I wish he would complain more, because it’s not good.”
At the same time, Hunter stressed that his father remains engaged with the issues and people that have defined much of his adult life.
“He’s still doing his thing,” Hunter said. “He so believes in this country.”
Reuters reported that a spokesman for the former president declined to comment on Hunter Biden’s description of the cancer having spread “further” beyond the bones. That means the precise current extent of the disease has not been independently detailed by Biden’s medical team in a public statement.
Jill had already acknowledged the seriousness of the bone metastasis during a June 1 appearance on NBC’s Today. She said at the time that her husband was “doing okay,” but explained that cancer spreading to bone made his case fundamentally different from prostate cancer confined to the prostate.
“I think Joe will live with cancer ’til the rest of his life,” Jill said.
She also spoke about the daily reality of caregiving, including making sure he eats properly, exercises and takes his medications. Her comments placed the Bidens’ experience in a broader context familiar to many families caring for relatives with long-term cancer or other serious illnesses.
Despite treatment, Biden has continued to make selected public appearances. Reuters reported that he attended the June dedication of Barack Obama’s presidential library in Chicago, and Jill said earlier this summer that he was continuing to travel, speak publicly and attend events even as treatment affected his stamina.
The former president is also preparing to publish a presidential memoir, Promise Me, America, on Nov. 17. In announcing the book in July, Biden said he had been spending significant time with his family while receiving cancer treatment and said the treatment was going well.
The book is expected to revisit major decisions from his presidency, including his decision to seek reelection in 2024 and his later decision to withdraw from the race. His health had been the subject of intense public debate during his presidency, particularly after his June 2024 debate performance, but his office has said he had not been diagnosed with prostate cancer before the diagnosis announced in May 2025.
The cancer diagnosis has also reopened a deeply personal chapter for the Biden family. Joe and Jill Biden’s son Beau died of glioblastoma, an aggressive brain cancer, in 2015 at age 46. His death became a major force behind Joe Biden’s long-running support for cancer research and the federal Cancer Moonshot initiative.
In another portion of her recent interview, Jill said she still turns to Beau in prayer as the family faces Joe’s illness, describing the late son as a continuing source of emotional strength. The experience of losing Beau, she suggested, shapes the way she now thinks about fear, uncertainty and the limits of what a family can control.
That history also helps explain why Jill’s latest comments combine frankness about mortality with a deliberate refusal to make illness the only subject of the family’s life. She has repeatedly acknowledged the seriousness of metastatic cancer while emphasizing that treatment, work, family and ordinary moments continue alongside it.
For now, the public picture remains mixed. Jill has described recent scans and PSA results as encouraging, while Hunter has described significant pain and further spread of the disease. Those statements are not necessarily contradictory: metastatic prostate cancer can respond to treatment in some areas while continuing to require long-term management in others.
What is clear from both accounts is that Joe Biden’s cancer remains a serious, ongoing condition rather than a resolved health episode. The former president continues treatment, his family continues to adjust around it, and Jill Biden says their focus is increasingly simple — to remain together, find joy where they can and make the most of the time ahead.
"🔥 POLITICAL EARTHQUAKE! — THE NEW EPSTEIN FILES TWIST THAT PUTS TRUMP UNDER MASSIVE SCRUTINY!"
A new wave of scrutiny surrounding the Jeffrey Epstein files is putting Donald Trump back at the center of one of Washington’s most contentious political battles. Representative Ted Lieu has publicly urged authorities and the media to examine disturbing allegations contained in Epstein-related records, while congressional Democrats continue pressing questions about how the Justice Department handled the documents.
The dispute reaches far beyond a single statement from a lawmaker. It involves allegations of sexual abuse, questions about the completeness of a major document release, and a growing political confrontation over whether the public has received a full accounting of the records connected to Epstein.
For Trump, the renewed attention creates another difficult political moment. For Lieu and other Democrats, the central question is whether the available records have received the scrutiny they warrant — and whether additional disclosures could clarify what investigators knew.
But there is an essential distinction at the heart of the controversy: an allegation appearing in an investigative file is not the same as a finding that the alleged conduct occurred.
Ted Lieu Brings the Epstein Allegations Back Into the Spotlight
Lieu, a California Democrat and vice chair of the House Democratic Caucus, drew attention to the allegations during a news conference on February 3, 2026.
He argued that Republicans’ focus on former President Bill Clinton and former Secretary of State Hillary Clinton risked diverting attention from references to Trump in the Epstein files. Lieu urged journalists to examine the allegations recorded in the documents and questioned whether the Justice Department was adequately investigating people connected to Epstein.
His remarks were forceful, but their meaning matters. Lieu was describing allegations contained in the records, not announcing that investigators had established the accusations as fact.
The distinction became particularly important as descriptions of his comments spread online. Some posts suggested that the files conclusively showed criminal conduct or that undisclosed records contained direct proof of abuse. Fact-checking reports found that such descriptions went beyond what Lieu actually said.
The documents include information gathered during investigations into Epstein, the convicted sex offender whose connections to wealthy and influential people have remained a source of public concern. Investigative records can contain witness accounts, tips, interview summaries, and information that has not been independently corroborated.
The presence of a person's name in such records does not, by itself, establish criminal conduct. Nor does the existence of an allegation automatically establish its credibility.
Lieu's intervention nevertheless intensified the debate over what the records contain, what the government has disclosed, and whether further investigative steps are warranted.
A Previously Withheld Set of Records Raises New Questions
The controversy took another turn in February when House Oversight Committee Democrats said the Justice Department appeared to have withheld documents concerning a woman who alleged that Trump sexually assaulted her when she was a minor.
According to reporting by ABC News, an index of materials associated with the investigation indicated that FBI agents had interviewed the woman multiple times in 2019. The public release initially appeared to include only one of several interview reports and related notes.
Democratic lawmakers said their review suggested that more than 50 pages of potentially relevant material had not appeared in the public database. They questioned whether the department had properly disclosed records covered by the release requirements.
The Justice Department disputed the Democrats’ characterization. It said responsive documents had been produced unless they fell into categories such as duplicates, privileged material, or records connected to an ongoing federal investigation.
That disagreement raises a substantive question: Were documents missing because of administrative or legal reasons, or did the release fail to include material that should have been made public?
Answering that question requires more than competing statements from politicians. It requires a careful examination of the document index, the records that were released, the records that remain unavailable, and the legal basis for withholding any material.
The department has attributed some problems in the broader release process to the scale and complexity of the records. Democrats have argued that the apparent gaps deserve further investigation.
The dispute has also intensified scrutiny of Attorney General Pam Bondi, who has faced congressional questions about the department’s handling of the Epstein files.
What the Allegation in the Records Actually Says
The allegations at issue are serious. According to ABC News, an FBI presentation summarized a woman's account that Epstein introduced her to Trump and that Trump subsequently assaulted her when she was between approximately 13 and 15 years old.
The account is an allegation, not an established finding of fact.
The public record also contains important limitations. An FBI interview summary documents what a witness told investigators; it does not necessarily establish that investigators independently verified the account. Likewise, the appearance of an allegation in a presentation prepared for prosecutors does not, on its own, demonstrate that prosecutors or investigators concluded it was substantiated.
ABC News reported that an internal FBI email indicated the woman ultimately declined to cooperate. That detail is relevant to understanding the investigative record, but it does not independently prove or disprove her account.
The Justice Department has said that some Epstein-related materials contain untrue or sensational claims submitted to the FBI. The White House has also rejected the allegations against Trump as baseless. Trump has denied wrongdoing.
Those responses do not resolve every question about the records or how they were handled. But they are part of the public record and must be considered alongside the allegations and the available documentation.
A responsible examination of the case must keep three issues separate: what a witness alleged, what investigators documented, and what evidence — if any — independently corroborates the allegation.
Confusing those categories can mislead readers and turn an unresolved claim into an apparent conclusion.
Why the Justice Department’s Handling of the Files Matters
The political conflict is not limited to the allegations involving Trump. It also concerns the government’s obligation to handle Epstein-related records transparently while protecting victims’ privacy and complying with legal restrictions.
The release process has attracted criticism over redactions, missing or delayed documents, and the disclosure of sensitive information. Epstein survivors and lawmakers have raised concerns about whether the process adequately balances public accountability with the need to protect people who experienced abuse.
That balance is difficult. Excessive redaction can prevent the public from understanding how authorities handled a major criminal investigation. Insufficient redaction can expose victims’ identities or release private material that should remain protected.
The Justice Department has said that some material must remain withheld for legal reasons, including protections for victims and restrictions involving ongoing investigations. Critics have questioned whether those explanations fully account for every apparent omission.
Congressional oversight could help establish how the department interpreted its obligations, what internal procedures it used, and whether any documents were improperly excluded. It could also determine whether apparent gaps resulted from administrative errors rather than deliberate concealment.
At this stage, the public dispute over the records should not be treated as proof of a coordinated cover-up. That is a conclusion that would require evidence beyond the existence of missing documents or disagreements over disclosure decisions.
The stakes are nonetheless substantial. The credibility of the release process depends on whether the government can explain its decisions and demonstrate that the rules were applied consistently.
A Political Clash With Consequences Beyond Trump
Lieu’s statements have become part of a wider confrontation between congressional Democrats and the Trump administration over the Epstein investigation.
Democrats have accused the Justice Department of failing to disclose all relevant records and have demanded greater transparency. Administration officials have countered that some claims circulating in public are unsubstantiated and that the department must follow legal requirements governing sensitive information.
The disagreement has created a political feedback loop: each new document or allegation generates demands for more disclosure, while each dispute over the release creates additional suspicion about what might remain unavailable.
That dynamic can make it difficult to distinguish legitimate unanswered questions from claims that go beyond the evidence.
For Democrats, continued scrutiny offers an opportunity to demand explanations from the administration and test whether the department complied with its obligations. For Trump and his allies, the challenge is to respond to questions about the records while arguing that unverified allegations should not be treated as proof of misconduct.
The political consequences will depend partly on what additional records show and whether independent evidence supports any of the claims. They will also depend on whether congressional inquiries establish procedural failures in the release process.
An investigation may uncover significant new information. It may also conclude that some allegations cannot be substantiated or that missing documents were withheld for legally permissible reasons. Neither outcome should be assumed in advance.
The Questions That Remain
The Epstein files have become a test of public trust in the institutions responsible for investigating abuse, protecting survivors, and disclosing records of legitimate public interest.
Several questions remain central. Were all responsive documents released under the applicable requirements? If material was withheld, what legal or administrative reasons justified the decision? What did investigators establish independently, and which statements remain uncorroborated allegations? And how can the government provide meaningful transparency without exposing survivors to further harm?
Lieu has pressed for greater scrutiny of allegations involving Trump, while other Democrats have focused on the department’s handling of the documents. Those efforts have renewed pressure on the administration, but public statements and congressional accusations are not substitutes for documented findings.
The next meaningful developments will come from the records themselves, any additional disclosures, and the results of formal oversight or investigative proceedings.
For now, the controversy remains a collision of serious allegations, disputed disclosure decisions, and partisan conflict. The public deserves clear answers about the documents and the process used to release them — without treating an allegation as a proven fact or dismissing legitimate questions before the evidence has been examined.
That is what will ultimately determine whether this latest Epstein files dispute produces meaningful accountability or becomes another chapter in Washington’s ongoing political battle.
